New Residential Investment Corp. Announces Fourth Quarter and Full Year 2021 Results
NEW YORK–(BUSINESS WIRE)–New Residential Investment Corp. (NYSE: NRZ; “New Residential” or the “Company”) today reported…
NEW YORK–(BUSINESS WIRE)–New Residential Investment Corp. (NYSE: NRZ; “New Residential” or the “Company”) today reported…
Former Biogen R&D chief and one of the most prolific drug developers in the field…
Bigtincan, whose sales enablement automation platform helps their customers deliver “The Buying Experience of the…
Leuven, BELGIUM, Boston, MA, US – February 8, 2022 – 08.00 AM CET – Oxurion…
Press Release Nicox’s Positive FDA Meeting Shows Clear Path for NCX 4251 in Dry Eye…
Potential 6,000+ Laser Communication Terminal Opportunity through Next Decade CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – Graph Blockchain Inc. (CSE: GBLC) (OTC Pink: REGRF)…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – Datametrex AI Limited (TSXV: DM) (FSE: D4G)…
Toronto, Ontario–(Newsfile Corp. – February 8, 2022) – ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF)…
Transatlantic Deals Veteran Goold Joins Wilson Sonsini’s London Office From EY Wilson Sonsini’s London Office…
Members will be able to leverage virtual primary care for primary care and urgent healthcare…
SoftBank to Explore Arm Public Offering SANTA CLARA, Calif. & TOKYO–(BUSINESS WIRE)–NVIDIA (NASDAQ: NVDA) and…
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland – February 8, 2022 Idorsia…
NEW YORK–(BUSINESS WIRE)–LIV Capital Acquisition Corp. II (the “Company”) announced today that it priced its…
MELBOURNE, Australia and KYOTO, Japan, Feb. 08, 2022 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX:…
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — The Board of Directors of Aleafia Health Inc….
LEIDEN, Netherlands & CAMBRIDGE, Mass., Feb. 07, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
TORONTO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX – XLY) (“Auxly”…
SAN FRANCISCO and SAN DIEGO, Feb. 07, 2022 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
– Dr. Beckman, a board-certified ophthalmologist, brings 30 years of experience in ophthalmology, drug development…